Table 3.
Medication Class | % Patients Filling Prescriptions | Proportion of Days Covered ≥80% | Medication Possession Ratio ≥80% |
---|---|---|---|
Asthma | |||
Any inhaled corticosteroid | 42 | 11 | 21 |
Chronic obstructive pulmonary disease | |||
Any anticholinergic | 21 | 44 | 51 |
Coronary artery disease | |||
Angiotensin-converting enzyme inhibitor/Angiotensin receptor blocker | 45 | 73 | 79 |
Any beta-blocker | 47 | 70 | 76 |
Statin | 57 | 68 | 74 |
Depression | |||
Selective serotonin reuptake inhibitor | 30 | 43 | 69 |
Serotonin-norepinephrine reuptake inhibitor | 5 | 43 | 68 |
Diabetes | |||
Biguanide | 37 | 58 | 67 |
Sulfonylurea | 21 | 59 | 69 |
Thiazolidinedione | 18 | 48 | 73 |
ACE inhibitor/angiotensin receptor blocker | 50 | 70 | 76 |
Statin | 49 | 64 | 70 |
Heart failure | |||
ACE inhibitor/angiotensin receptor blocker | 53 | 69 | 77 |
Appropriate beta-blocker* | 28 | 20 | 77 |
Any beta-blocker | 53 | 67 | 75 |
Hyperlipidemia | |||
Statin | 38 | 60 | 67 |
Hypertension | |||
ACE inhibitor/angiotensin receptor blocker | 47 | 71 | 77 |
Beta-blocker | 26 | 70 | 77 |
Calcium channel blocker | 16 | 62 | 79 |
Diuretic | 33 | 64 | 74 |
Appropriate beta-blocker includes 3 specific medications based on the American College of Cardiology/American Heart Association heart failure guidelines.